InsidersTradesSigma
Cigna Corp Stock: price and management transactions · United States · SEC (Form 4)
Follow the Cigna Corp share price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Cigna Corp has recorded 182 reports. Market capitalisation: €75.5bn. The latest transaction was disclosed on 8 February 2023 (Don). Among the most active insiders: Cordani David. All data is openly available.
182
Insider Decl.
0
Thresholds
€179,039
2 ops.
Buy Volume
€5m
9 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Cigna Corp Strong Buy (bullish), based on 24 analysts. Average price target: US$340.50.
53Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 8 February 2023
Declarations182 total
200 shares0Common Stock, $.01 Par ValueSEC:0001225208-23-001581:0
50,700 shares0Common Stock, $.01 Par ValueSEC:0001225208-23-000595:0
3,009 shares@ US$139.2239.5% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-012918:0
9,781 shares@ US$197.3538.0% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-012577:0
2,452 shares0Common Stock, $.01 Par ValueSEC:0001225208-22-011589:0
373 shares@ US$300.0030.0% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-011022:0
4,000 shares@ US$300.00148.0% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-011021:0
902 shares@ US$285.4643.5% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-010384:0
6,060 shares@ US$139.2252.8% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-010321:0
1,749 shares0Common Stock, $.01 Par ValueSEC:0001225208-22-010083:0
7,044 shares@ US$58.7396.9% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-009439:0
374 shares@ US$285.0027.3% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-009440:0
902 shares@ US$273.987.0% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-009254:0
9,505 shares@ US$149.13528.8% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-008760:0
5,094 shares@ US$192.0228.1% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-008762:0
5,557 shares@ US$120.89525.8% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-008763:0
374 shares@ US$275.0026.4% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-008761:0
3,458 shares@ US$139.220.0006% mcap28.5% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-008322:0
5,901 shares@ US$139.220.0010% mcap32.0% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-007208:0
45,261 shares@ US$120.8950.0069% mcap22.7% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-007209:0
757 shares0Common Stock, $.01 Par ValueSEC:0001225208-22-006303:0
757 shares0Common Stock, $.01 Par ValueSEC:0001225208-22-006301:0
757 shares0Common Stock, $.01 Par ValueSEC:0001225208-22-006309:0
757 shares0Common Stock, $.01 Par ValueSEC:0001225208-22-006306:0
757 shares0Common Stock, $.01 Par ValueSEC:0001225208-22-006302:0
25 of 182 declarations
About Cigna Corp
Cigna Corp, now operating under The Cigna Group, is one of the leading U.S. health care companies listed in the United States and traded on the NYSE under ticker CI. The company is headquartered in Bloomfield, Connecticut, United States. Over time, Cigna evolved from a traditional health insurer into a diversified managed health care platform that combines insurance coverage with pharmacy, clinical, and care-delivery services. The group is organized around two core businesses: Cigna Healthcare and Evernorth Health Services. Cigna Healthcare provides medical, dental, behavioral health, Medicare-related, government, employer-sponsored, individual, and international health benefits. Evernorth Health Services houses the company’s health services platform, including pharmacy benefit management, specialty pharmacy, home delivery, clinical support services, and behavioral health solutions. This structure gives Cigna a distinctive competitive profile, because it captures both premium-based insurance revenue and service-based healthcare revenues, while also helping the group manage medical cost trends more actively. From an investor perspective, Cigna’s appeal lies in the breadth of its platform, the recurring nature of its customer relationships, and its ability to integrate benefits administration with care services. Its product set includes medical plans, pharmacy solutions, dental and vision coverage, behavioral health programs, wellness tools, cost-management programs, and digital health offerings. The company serves employers, government programs, consumers, brokers, consultants, and health care providers, with a broad footprint in the United States and selected international markets. The latest annual report shows that the vast majority of external revenue is generated in the United States, underscoring the company’s primarily domestic earnings base. Recent developments have centered on portfolio optimization, clinical access initiatives, and capital management. In 2025, Cigna Healthcare announced executive leadership changes and continued to highlight programs aimed at improving access to care, including digital musculoskeletal care and behavioral health support. The company also remained active in balance-sheet management, including debt tender activity previously disclosed by management. Overall, Cigna remains a major name in the Health Care sector, supported by its scale, integrated model, and strong positioning in a highly regulated, competitive U.S. market where affordability, network breadth, and care coordination are critical differentiators.
